Trial NCT00862082

View at ClinicalTrials.gov 
Aliases: NCT00838604
Org. Study IDs: PR104-2002

Last trial update was posted on 2013-08-23

MeSH Interventions

Nitrogen Mustard Compounds Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

PR104 plus sorafenib was poorly tolerated in patients with advanced HCC

Limitations And Caveats

Early termination leading to small numbers of subjects analyzed. Phase II part of study never initiated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID